Patents by Inventor David A. Mann

David A. Mann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240265926
    Abstract: A hybrid edge and cloud system for detecting and identifying bird vocalizations including an edge device having an edge neural network. The edge neural network is trained with audio samples for making predictions about identification of the bird vocalizations. The system includes an audio sensor connected to the edge neural network for sending sound information to the edge neural network. The system includes a cloud computing system having a cloud neural network for processing the sound information, a first storage service, a second storage service, and a hit table which stores metadata about sound detections. The edge neural network generates a score for each of the trained audio samples based on predictions made from a sound audio clip and selects a top scoring audio sample. The hybrid edge and cloud system includes a browsing device having access to the cloud computing system and may request information from the hit table.
    Type: Application
    Filed: December 20, 2023
    Publication date: August 8, 2024
    Inventors: David A. Mann, Austin T. Anderson
  • Publication number: 20190263852
    Abstract: Provided are deglycosylation methods designed to optimize the yield of a Veratrum alkaloid from Veratrum plant material and/or from an extract of Veratrum plant material.
    Type: Application
    Filed: August 30, 2018
    Publication date: August 29, 2019
    Inventors: Gamini Senerath Jayatilake, Steven L. Richheimer, David A. Mann
  • Publication number: 20180305669
    Abstract: Provided herein are methods of producing three-dimensional (3-D) microtissue from a starting cell suspension of pluripotent stem cell (PSC)-derived hepatocytes. Such a method may comprise supplementing the cell suspension with cell adhesion-promoting components and culturing the PSC-derived hepatocytes on a non-adhesive surface to produce the microtissue.
    Type: Application
    Filed: June 29, 2018
    Publication date: October 25, 2018
    Applicants: FUJIFILM Cellular Dynamics, Inc., FUJIFILM Corporation
    Inventors: Michael Kenneth HANCOCK, Coby Bennett CARLSON, David A. MANN, Yuta MURAKAMI
  • Publication number: 20160168193
    Abstract: Provided are deglycosylation methods designed to optimize the yield of a Veratrum alkaloid from Veratrum plant material and/or from an extract of Veratrum plant material.
    Type: Application
    Filed: February 22, 2016
    Publication date: June 16, 2016
    Inventors: Gamini Senerath Jayatilake, Steven L. Richheimer, David A. Mann
  • Patent number: 8609706
    Abstract: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Grant
    Filed: May 15, 2012
    Date of Patent: December 17, 2013
    Assignee: Infinity Discovery, Inc.
    Inventors: Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward B. Holson, Brian T. Hopkins, Gregg F. Keaney, Nii O. Koney, Tao Liu, David A. Mann, Marta Nevalainen, Stephane Peluso, Lawrence Blas Perez, Daniel A. Snyder, Thomas T. Tibbitts
  • Publication number: 20130131063
    Abstract: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Application
    Filed: May 15, 2012
    Publication date: May 23, 2013
    Applicant: Infinity Pharmaceuticals, Inc.
    Inventors: Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward B. Holson, Brian T. Hopkins, Gregg F. Keaney, Nii O. Koney, Tao Liu, David A. Mann, Marta Nevalainen, Stephane Peluso, Lawrence Blas Perez, Daniel A. Snyder, Thomas T. Tibbitts
  • Patent number: 8178690
    Abstract: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Grant
    Filed: April 19, 2011
    Date of Patent: May 15, 2012
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward B. Holson, Brian T. Hopkins, Gregg F. Keaney, Nii O. Koney, Tao Liu, David A. Mann, Marta Nevalainen, Stephane Peluso, Lawrence Blas Perez, Daniel A. Snyder, Thomas T. Tibbitts
  • Publication number: 20110213145
    Abstract: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Application
    Filed: April 19, 2011
    Publication date: September 1, 2011
    Applicant: Infinity Discovery, Inc.
    Inventors: Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward B. Holson, Brian T. Hopkins, Gregg F. Keaney, Nii O. Koney, Tao Liu, David A. Mann, Marta Nevalainen, Stephane Peluso, Lawrence B. Perez, Daniel A. Snyder, Thomas T. Tibbitts
  • Patent number: 7928244
    Abstract: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: April 19, 2011
    Assignee: Infinity Discovery, Inc.
    Inventors: Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward B. Holson, Brian T. Hopkins, Gregg F. Keaney, Nii O. Koney, Tao Liu, David A. Mann, Marta Nevalainen, Stephane Peluso, Lawrence B. Perez, Daniel A. Snyder, Thomas T. Tibbitts
  • Patent number: 7851637
    Abstract: One aspect of the present invention relates to heterocyclic compounds that bind to bcl proteins and inhibit Bcl function. Another aspect of the present invention relates to compositions comprising a heterocyclic compound of the invention. The present invention provides methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: December 14, 2010
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Alfredo C. Castro, Wei Deng, Kristopher M. Depew, Michael A. Foley, Christian C. Fritz, Asimina T. Georges Evangelinos, Michael J. Grogan, Nafeeza Hafeez, Edward B. Holson, Brian T. Hopkins, Nii O. Koney, Tao Liu, David A. Mann, Lisa A. Marcaurelle, Daniel A. Snyder, Dennis J. Underwood, Andrew A. Wylie, Lin-Chen Yu, Linping Zhang
  • Publication number: 20100003728
    Abstract: Provided are deglycosylation methods designed to optimize the yield of Veratrum alkaloid from Veratrum plant material and/or from an extract of Veratrum plant material.
    Type: Application
    Filed: July 1, 2009
    Publication date: January 7, 2010
    Inventors: Gamini Senerath Jayatilake, Steven L. Richheimer, David A. Mann
  • Patent number: 6842964
    Abstract: An electrostatic speaker is constructed using a thin flexible membrane as the active member. This membrane is uniformly positioned against at least one printed circuit board containing at least one stator fixed in the PCB. Variations in structure are provided, all including at least one PCB and a membrane. In a preferred embodiment, intermeshing opposing ridges on the PCBs are adjacent to a central vibrating area of the membrane, and serve to position and tension the membrane. Attachment means connect the PCBs together, and electrical connections permit the passage of current to bias the membrane and to drive the stators to vibrate the membrane, producing acoustical output in the sonic or ultrasonic ranges. The invention also relates to the electrostatic speakers produced by this method of manufacture.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: January 18, 2005
    Assignee: Tucker Davis Technologies, Inc.
    Inventors: Timothy J. Tucker, David A. Mann, Willard W. Wilson
  • Patent number: 5951564
    Abstract: The invention is directed to an orthopaedic apparatus 24, 80, 380, 480, 580 for positioning an implant 22, 322, 422 relative to an end of a bone. The implant has at least one extractor opening 30, 330, 430 and a shoulder 26, 326, 426 with a slot therein. The positioning apparatus includes a shaft 32, 82, 382, 482 having a fixed impactor tip at an end thereof. The impactor tip is configured to be received within the implant slot. At least one clamping jaw is connected to the shaft, and includes a projection which is configured to be received in the at least one extractor opening. The at least one clamping jaw is preferably detachably connected to the shaft.
    Type: Grant
    Filed: December 18, 1996
    Date of Patent: September 14, 1999
    Assignee: Bristol-Myers Squibb Company
    Inventors: Lisa K. Schroder, David A. Mann, G. Kris Kumar, Steven C. Kitch, Paul F. Hickey, Timothy K. Doolin, Philip H. Cripe, Kim C. Bertin
  • Patent number: 5888245
    Abstract: The invention is directed to an alignment device for aligning a prosthetic hip stem implant with an opening formed in a proximal femur. The hip stem implant includes a landmark and the proximal femur includes a visual alignment mark. The alignment device includes an implant engaging portion configured for attachment with the landmark on the hip stem implant. The alignment device also includes a needle indicator connected with the implant engaging portion and having an end which may be positioned relative to the visual alignment mark on the proximal femur, thereby aligning the prosthetic hip stem implant relative to the opening in the proximal femur.
    Type: Grant
    Filed: May 21, 1997
    Date of Patent: March 30, 1999
    Assignee: Bristol-Myers Squibb Company
    Inventors: Steven Lee Meulink, David A. Mann
  • Patent number: 5459038
    Abstract: Nucleic acid isolates capable of hybridizing only to the Y-chromosome specific DNA sequences of cattle, sheep and goats are described, as are methods for the determination of the sex chromosome constitution of a tissue or cell sample.
    Type: Grant
    Filed: December 30, 1993
    Date of Patent: October 17, 1995
    Assignee: Advanced Riverina Holdings, Ltd.
    Inventors: Kenneth C. Reed, Eric A. Lord, Klaus I. Matthaei, David A. Mann, Sandra Beaton, Charles M. Herr, Margaret E. Matthews
  • Patent number: D390954
    Type: Grant
    Filed: March 28, 1996
    Date of Patent: February 17, 1998
    Assignee: Zimmer, Inc.
    Inventors: G. Kris Kumar, David A. Mann
  • Patent number: D397220
    Type: Grant
    Filed: March 28, 1996
    Date of Patent: August 18, 1998
    Assignee: Zimmer, Inc.
    Inventors: G. Kris Kumar, David A. Mann